Opioid use disorder and treatment: Challenges and opportunities

Kim A. Hoffman, Javier Ponce Terashima, Dennis McCarty

Research output: Contribution to journalReview article

Abstract

Background: Addiction health service researchers have focused efforts on opioid use disorder (OUD) and strategies to address the emerging public health threats associated with the epidemics of opioid use and opioid overdose. The increase in OUD is associated with widespread access to prescription opioid analgesics, enhanced purity of heroin, the introduction of potent illicit fentanyl compounds, and a rising tide of opioid overdose fatalities. These deaths have become the face of the opioid epidemic. Main Text: OUD is a chronic disorder that usually requires both medications for opioid use disorder (MOUD) and psychosocial treatment and support. Research has found that MOUD with an opioid receptor agonist (methadone), partial agonist (buprenorphine), or opioid antagonist (extended-release naltrexone) can support recovery. Despite compelling evidence that MOUD are effective, they remain underutilized. More research is needed on these therapies to understand the feasibility of implementation in clinic settings. Conclusion: This special issue focuses on how health services research has emerged as an important contributor to efforts to control the opioid epidemic in North America and Europe.

Original languageEnglish (US)
Article number884
JournalBMC health services research
Volume19
Issue number1
DOIs
StatePublished - Nov 25 2019

Fingerprint

Opioid Analgesics
Buprenorphine
Naltrexone
Narcotic Antagonists
Health Services Research
Methadone
Heroin
Opioid Receptors
Fentanyl
North America
Research
Health Services
Prescriptions
Public Health
Research Personnel

ASJC Scopus subject areas

  • Health Policy

Cite this

Opioid use disorder and treatment : Challenges and opportunities. / Hoffman, Kim A.; Ponce Terashima, Javier; McCarty, Dennis.

In: BMC health services research, Vol. 19, No. 1, 884, 25.11.2019.

Research output: Contribution to journalReview article

Hoffman, Kim A. ; Ponce Terashima, Javier ; McCarty, Dennis. / Opioid use disorder and treatment : Challenges and opportunities. In: BMC health services research. 2019 ; Vol. 19, No. 1.
@article{39c48c797ca246b593c36b27efc1e88d,
title = "Opioid use disorder and treatment: Challenges and opportunities",
abstract = "Background: Addiction health service researchers have focused efforts on opioid use disorder (OUD) and strategies to address the emerging public health threats associated with the epidemics of opioid use and opioid overdose. The increase in OUD is associated with widespread access to prescription opioid analgesics, enhanced purity of heroin, the introduction of potent illicit fentanyl compounds, and a rising tide of opioid overdose fatalities. These deaths have become the face of the opioid epidemic. Main Text: OUD is a chronic disorder that usually requires both medications for opioid use disorder (MOUD) and psychosocial treatment and support. Research has found that MOUD with an opioid receptor agonist (methadone), partial agonist (buprenorphine), or opioid antagonist (extended-release naltrexone) can support recovery. Despite compelling evidence that MOUD are effective, they remain underutilized. More research is needed on these therapies to understand the feasibility of implementation in clinic settings. Conclusion: This special issue focuses on how health services research has emerged as an important contributor to efforts to control the opioid epidemic in North America and Europe.",
author = "Hoffman, {Kim A.} and {Ponce Terashima}, Javier and Dennis McCarty",
year = "2019",
month = "11",
day = "25",
doi = "10.1186/s12913-019-4751-4",
language = "English (US)",
volume = "19",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Opioid use disorder and treatment

T2 - Challenges and opportunities

AU - Hoffman, Kim A.

AU - Ponce Terashima, Javier

AU - McCarty, Dennis

PY - 2019/11/25

Y1 - 2019/11/25

N2 - Background: Addiction health service researchers have focused efforts on opioid use disorder (OUD) and strategies to address the emerging public health threats associated with the epidemics of opioid use and opioid overdose. The increase in OUD is associated with widespread access to prescription opioid analgesics, enhanced purity of heroin, the introduction of potent illicit fentanyl compounds, and a rising tide of opioid overdose fatalities. These deaths have become the face of the opioid epidemic. Main Text: OUD is a chronic disorder that usually requires both medications for opioid use disorder (MOUD) and psychosocial treatment and support. Research has found that MOUD with an opioid receptor agonist (methadone), partial agonist (buprenorphine), or opioid antagonist (extended-release naltrexone) can support recovery. Despite compelling evidence that MOUD are effective, they remain underutilized. More research is needed on these therapies to understand the feasibility of implementation in clinic settings. Conclusion: This special issue focuses on how health services research has emerged as an important contributor to efforts to control the opioid epidemic in North America and Europe.

AB - Background: Addiction health service researchers have focused efforts on opioid use disorder (OUD) and strategies to address the emerging public health threats associated with the epidemics of opioid use and opioid overdose. The increase in OUD is associated with widespread access to prescription opioid analgesics, enhanced purity of heroin, the introduction of potent illicit fentanyl compounds, and a rising tide of opioid overdose fatalities. These deaths have become the face of the opioid epidemic. Main Text: OUD is a chronic disorder that usually requires both medications for opioid use disorder (MOUD) and psychosocial treatment and support. Research has found that MOUD with an opioid receptor agonist (methadone), partial agonist (buprenorphine), or opioid antagonist (extended-release naltrexone) can support recovery. Despite compelling evidence that MOUD are effective, they remain underutilized. More research is needed on these therapies to understand the feasibility of implementation in clinic settings. Conclusion: This special issue focuses on how health services research has emerged as an important contributor to efforts to control the opioid epidemic in North America and Europe.

UR - http://www.scopus.com/inward/record.url?scp=85075564465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075564465&partnerID=8YFLogxK

U2 - 10.1186/s12913-019-4751-4

DO - 10.1186/s12913-019-4751-4

M3 - Review article

C2 - 31767011

AN - SCOPUS:85075564465

VL - 19

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 884

ER -